BSE Live
Nov 07, 16:01Prev. Close
442.10
Open Price
441.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 07, 15:55Prev. Close
441.75
Open Price
436.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Venus Remedies (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 4.51 | 57.17 | 58.80 | 51.22 | 50.62 | |
| Diluted EPS (Rs.) | 4.51 | 56.19 | 54.36 | 48.32 | 50.63 | |
| Cash EPS (Rs.) | 44.71 | 91.34 | 85.74 | 74.22 | 71.42 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 399.13 | 403.43 | 359.63 | 315.43 | 259.52 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 399.13 | 403.43 | 359.63 | 315.43 | 259.52 | |
| Revenue from Operations/Share (Rs.) | 405.52 | 473.31 | 444.54 | 420.69 | 397.72 | |
| PBDIT/Share (Rs.) | 78.53 | 121.22 | 114.34 | 106.31 | 99.11 | |
| PBIT/Share (Rs.) | 38.33 | 86.07 | 82.97 | 80.41 | 78.32 | |
| PBT/Share (Rs.) | 2.31 | 60.37 | 59.61 | 52.20 | 57.65 | |
| Net Profit/Share (Rs.) | 4.51 | 56.19 | 54.36 | 48.32 | 50.63 | |
| NP After MI And SOA / Share (Rs.) | 4.51 | 56.19 | 54.36 | 48.32 | 50.63 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 19.36 | 25.61 | 25.72 | 25.26 | 24.91 | |
| PBIT Margin (%) | 9.45 | 18.18 | 18.66 | 19.11 | 19.69 | |
| PBT Margin (%) | 0.57 | 12.75 | 13.40 | 12.40 | 14.49 | |
| Net Profit Margin (%) | 1.11 | 11.87 | 12.22 | 11.48 | 12.72 | |
| NP After MI And SOA Margin (%) | 1.11 | 11.87 | 12.22 | 11.48 | 12.72 | |
| Return on Networth/Equity (%) | 1.13 | 13.92 | 15.11 | 15.31 | 19.50 | |
| Return on Capital Employed (%) | 0.80 | 10.31 | 10.88 | 11.18 | 13.74 | |
| Return on Assets (%) | 0.61 | 7.70 | 7.98 | 8.20 | 10.02 | |
| Total Debt/Equity (X) | 0.62 | 0.54 | 0.59 | 0.59 | 0.64 | |
| Asset Turnover Ratio (%) | 55.16 | 64.90 | 65.31 | 71.39 | 78.78 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.36 | 1.29 | 1.18 | 1.11 | 1.11 | |
| Quick Ratio (X) | 0.63 | 0.62 | 0.51 | 0.48 | 0.51 | |
| Inventory Turnover Ratio (X) | 3.25 | 3.81 | 3.66 | 4.26 | 4.81 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 5.10 | 6.20 | 5.92 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 3.23 | 4.04 | 4.20 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 94.90 | 93.80 | 94.08 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 96.77 | 95.96 | 95.80 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 1.06 | 3.35 | 3.55 | 2.85 | 3.79 | |
| Interest Coverage Ratios (Post Tax) (%) | 1.06 | 3.35 | 3.55 | 2.85 | 3.79 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 432.91 | 526.96 | 472.66 | 339.54 | 332.26 | |
| EV/Net Operating Revenue (X) | 0.93 | 0.97 | 1.01 | 0.83 | 0.92 | |
| EV/EBITDA (X) | 4.82 | 3.80 | 3.92 | 3.28 | 3.67 | |
| MarketCap/Net Operating Revenue (X) | 0.33 | 0.52 | 0.54 | 0.39 | 0.51 | |
| Retention Ratios (%) | 0.00 | 0.00 | 94.89 | 93.79 | 94.07 | |
| Price/BV (X) | 0.33 | 0.61 | 0.67 | 0.52 | 0.78 | |
| Price/Net Operating Revenue | 0.33 | 0.52 | 0.54 | 0.39 | 0.51 | |
| Earnings Yield | 0.03 | 0.23 | 0.23 | 0.29 | 0.25 |
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y